A special task force established by the European League Against Rheumatism (EULAR) has developed 4 overall principles and 10 specific recommendations to ensure that physical activity is a part of the standard of care among patients diagnosed with rheumatoid arthritis (RA), spondyloarthritis, and osteoarthritis in Europe.
A special task force established by the European League Against Rheumatism (EULAR) has developed 4 overall principles and 10 specific recommendations to ensure that physical activity (PA) is a part of the standard of care among patients diagnosed with rheumatoid arthritis (RA), spondyloarthritis (SpA), and osteoarthritis (OA) in Europe.
Although the World Health Organization and the American College of Sports Medicine (ACSM) have developed general guidance for PA among healthy adults, uptake among individuals with rheumatic diseases is less, likely due to a fear of joint damage or flare-ups among both patients and their care providers. While existing EULAR guidelines1 and those by ACSM recommend exercise or PA, they lack in specifics on the type and dose of exercise.
The EULAR task force—composed of 22 European PA experts, 1 orthopedic surgeon, 9 physiotherapists, 1 psychologist, 1 occupational therapy nurse, and 1 human movement specialist—was therefore commissioned to:2
Read about how low-dose rituximab can help control RA symptoms.
ACSM’s position stand was followed and the group kicked off the process by agreeing on the definitions of exercise and PA. The group conducted 2 systematic literature searches and meta-analyzed studies that measured efficacy of PA interventions. Results from here were used to develop the overarching principles as well as the specific recommendations during a face-to-face meeting, followed by independent and anonymous voting by the task force members to establish the level of agreement on these recommendations. The objective was to understand the barriers and facilitators of PA intervention in the said patient population.
The 4 overarching principles state that:
Specific recommendations by the task force include:
The guidelines have been developed for care providers, patient advocacy groups, and policy makers.
References
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
March 21st 2025Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions
March 21st 2025In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Read More
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More